Watchlist Price Alert

Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

3.90

-0.02 (-0.51%)

At close: Jun 17, 2025, 3:59 PM

3.92

0.38%

Pre-market: Jun 18, 2025, 05:58 AM EDT

Lexeo Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Cash & Equivalents	28.91M	35.01M	157.02M	174.98M	195.06M	121.47M	35.45M	45.54M	58.85M	77.33M
Short-Term Investments	70.92M	86.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	7.04M	7.01M	n/a	3.25M	3.25M	n/a	n/a	n/a	3.26M	n/a
Other Long-Term Assets	3.25M	3.25M	3.25M	n/a	n/a	3.25M	3.25M	3.25M	n/a	3.25M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.44M	4.6M	2.44M	2.17M	3.03M	3K	2.01M	1.24M	2.37M	371K
Total Current Assets	105.27M	126.12M	159.46M	177.15M	198.09M	124.29M	38.87M	48.71M	61.22M	80.05M
Property-Plant & Equipment	10.13M	10.56M	11.15M	11.61M	11.86M	12.26M	12.6M	12.97M	13.34M	13.78M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.42M	20.82M	14.41M	14.86M	15.12M	15.51M	15.85M	16.23M	16.6M	17.03M
Total Assets	125.69M	146.94M	173.87M	192.01M	213.21M	139.81M	54.72M	64.94M	77.82M	97.08M
Account Payables	11.98M	6.42M	8.44M	5.76M	4.3M	3.79M	2.65M	2.37M	3.91M	2.68M
Deferred Revenue	n/a	n/a	n/a	-10.99M	-2.61M	n/a	n/a	n/a	448.7K	n/a
Short-Term Debt	n/a	n/a	n/a	2.67M	2.61M	2.6M	4.15M	n/a	2.75M	n/a
Other Current Liabilities	1.7M	4.66M	15.7M	-586K	-1.49M	602K	2M	2.4M	6.58M	2.15M
Total Current Liabilities	30.82M	22.85M	26.82M	18.88M	21.63M	17.24M	23.04M	13.66M	13.69M	14.35M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	185.03M	185.03M	n/a	185.03M
Total Long-Term Liabilities	6.75M	7.25M	7.72M	8.18M	8.63M	9.03M	194.5M	194.9M	10.28M	195.68M
Total Liabilities	37.58M	30.1M	34.54M	27.06M	30.25M	26.27M	217.53M	208.56M	23.97M	210.03M
Total Debt	9.4M	9.92M	10.4M	10.85M	11.24M	11.64M	16.21M	12.66M	13.03M	13.48M
Common Stock	3K	3K	3K	3K	3K	3K	n/a	2K	1.71K	n/a
Retained Earnings	-312.83M	-280.17M	-254.25M	-224.76M	-203.52M	-181.84M	-167.65M	-147.54M	-134.1M	-115.45M
Comprehensive Income	-54K	-103K	n/a	n/a	n/a	n/a	n/a	-185.03M	-1.71K	n/a
Shareholders Equity	88.11M	116.84M	139.33M	164.95M	182.95M	113.53M	-162.81M	-143.62M	53.85M	-112.95M
Total Investments	77.95M	93.52M	n/a	3.25M	3.25M	3.25M	3.25M	3.25M	3.26M	n/a